Although bariatric surgery is proven to sustain weight loss in morbidly obese patients, long-term adverse effects have yet to be fully characterized. This study compared the long-term consequences of two common forms of bariatric surgery: one-anastomosis gastric bypass (oAGB) and Roux-en-Y Gastric Bypass (RYGB) in a preclinical rat model. We evaluated the influence of biliopancreatic limb (BPL) length, malabsorption, and bile acid (BA) reflux on esogastric mucosa. After 30 weeks of follow-up, Wistar rats operated on RYGB, OAGB with a short BPL (15 cm, OAGB-15), or a long BPL (35 cm, OAGB-35), and unoperated rats exhibit no cases of esogastric cancer, metaplasia, dysplasia, or Barrett's esophagus. Compared to RYGB, OAGB-35 rats presented higher rate of esophagitis, fundic gastritis and perianastomotic foveolar hyperplasia. OAGB-35 rats also revealed the greatest weight loss and malabsorption. on the contrary, BA concentrations were the highest in the residual gastric pouch of OAGB-15 rats. Yet, no association could be established between the esogastric lesions and malabsorption, weight loss, or gastric bile acid concentrations. in conclusion, RYGB results in a better long-term outcome than OAGB, as chronic signs of biliary reflux or reactional gastritis were reported post-oAGB even after reducing the BpL length in a preclinical rat model. Bariatric surgery is widely accepted as a long-term effective treatment for morbid obesity and ensuing metabolic disorders 1. One anastomosis gastric bypass (OAGB) is a promising procedure, first reported in 1997 2. This intervention has been proven safe 2 with some studies even reporting a lower rate of post-operative morbidity compared to the gold standard, Roux-en-Y gastric bypass (RYGB) 3,4. Additionally, OAGB may be preferred to RYGB due to its convenient ability to be reversed 5 and revised 6. Its efficiency in terms of weight loss and control of comorbidities has been widely characterized in the last several decades 7-9 , prompting its potential as an improved alternative to RYGB 7. However, OAGB is still debated due to chronic risks associated with potential biliary reflux 10 on the esogastric tract. OAGB, as all Omega-loop surgical strategies, is characterized by the direct anastomosis of the biliopancreatic loop to the stomach, instead of interposing an alimentary loop as in the Roux-en-Y procedures. This anatomically exposes the esogastric tract to bile acids (BA). In rats, the negative consequences of Omega-loop surgical strategies are well known 11,12. Esojejunal or esoduodenal anastomoses have been reported as experimental models of